Medication info
Jeil Atorvastatin Tablet 10 mg (Atorvastatin Calcium Hydrate)

Jeil Atorvastatin Tablet 10 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›10.85mg / 1 tablet
Manufacturer / importer
Jeil Health Science Co., Ltd.
Appearance
White, round, film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903557 · Approved 2019.05.29 · Insurance code 664102680

Summary

Main use
Improves hyperlipidemia and helps prevent cardiovascular diseases (including myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients taking atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take the medicine at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Children's dosage
Pediatric patients (10 ~ 17 years of age) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Jeil Health Science Co., Ltd.

Efficacy & effects

Improves hyperlipidemia and helps prevent cardiovascular diseases (including myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • hyperlipidemia
  • primary hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It lowers the risks of myocardial infarction and stroke, particularly effective for adults with multiple risk factors and patients with type 2 diabetes. It is also used to reduce the risk of vascular reconstruction surgery and chronic stable angina. In the treatment of dyslipidemia, it lowers total cholesterol and LDL cholesterol levels while increasing HDL cholesterol. It also helps reduce cholesterol levels in pediatric patients with familial hypercholesterolemia. Therefore, it is effectively used to reduce the risk of cardiovascular diseases and treat dyslipidemia.

Dosage and Administration

Adult dosage

Patients taking atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take the medicine at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.

Children's dosage

Pediatric patients (10 ~ 17 years of age) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle-related adverse effects, so report any symptoms such as muscle pain, cramps, or weakness to your doctor immediately. Especially, the medication should be discontinued if there is a significant elevation in muscle enzyme levels or suspicion of severe myopathy. If there are liver function issues or signs of hepatitis, discontinuation should be done and consult with a doctor. Pregnant women or those who may become pregnant, as well as nursing mothers, should not take this medication. It is not to be administered to children, especially those under the age of 10. Special caution is required for patients with a history of alcoholism or liver disease, kidney impairment, or hypothyroidism. Drug interactions may occur when taken with other medications, so inform your doctor or pharmacist of any current medications. Avoid consuming grapefruit juice as it may increase the blood concentration of this medication and increase the risk of side effects. This medication contains lactose, so patients with lactose intolerance should not take it. Elderly patients or those with kidney disorders should closely monitor muscle condition as they are at higher risk of myopathy. There is no specific antidote in case of overdose, so treatment should be according to symptoms, and liver function and muscle enzyme levels should be regularly tested. Keep this medication out of reach of children and store it in its original container.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 169 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorder
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • skin-mucosa syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urine leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test values
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • dizziness
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrosis
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • hypoglycemia
  • increased appetite
  • vasculogenic edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive error
  • retinal hemorrhage
  • hearing impairment
  • glaucoma
  • dysgeusia
  • ageusia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to store it at room temperature between 1 to 30 degrees Celsius. Storing it in this manner helps maintain the efficacy of the medication and ensures safe use.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.